A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity

NCT00210808 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

407

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Binge-Eating Disorder

Interventions

DRUG: topiramate

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators

[object Object]